$CDNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CareDx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CareDx, Inc.. Get notifications about new insider transactions in CareDx, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 03 2018 | CDNA | CareDx, Inc. | King Sasha | Chief Commercial Of ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | King Sasha | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 71,500 | 61.5 K to 71.5 K (+16.26 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | King Sasha | Chief Commercial Of ... | Grant | A | 0.00 | 50,000 | 0 | 61,500 | 11.5 K to 61.5 K (+434.78 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Grant | A | 0.00 | 25,000 | 0 | 89,738 | 64.7 K to 89.7 K (+38.62 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 64,738 | 14.7 K to 64.7 K (+339.26 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 12.24 | 150,000 | 1,836,000 | 150,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Grant | A | 0.00 | 50,000 | 0 | 472,037 | 422 K to 472 K (+11.85 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Grant | A | 0.00 | 150,000 | 0 | 422,037 | 272 K to 422 K (+55.14 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Abernethy Amy | Director | Option Exercise | A | 12.88 | 30,000 | 386,400 | 30,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Abernethy Amy | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,197 | 0 | 69,996 | 68.8 K to 70 K (+1.74 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 1,197 | 0 | 52,204 | 51 K to 52.2 K (+2.35 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 740 | 0 | 40,272 | 39.5 K to 40.3 K (+1.87 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 1,756 | 0 | 132,879 | 131.1 K to 132.9 K (+1.34 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 5,000 | 0 | 37,901 | 32.9 K to 37.9 K (+15.20 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 68,799 | 63.8 K to 68.8 K (+7.84 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,000 | 0 | 51,007 | 46 K to 51 K (+10.87 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 5,000 | 0 | 39,532 | 34.5 K to 39.5 K (+14.48 %) |
| Jul 03 2018 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Option Exercise | A | 14.74 | 15,000 | 221,100 | 15,000 | |
| Jul 03 2018 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 5,000 | 0 | 131,123 | 126.1 K to 131.1 K (+3.96 %) |
| May 29 2018 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Gift | G | 0.00 | 50,000 | 0 | 878,768 | 928.8 K to 878.8 K (-5.38 %) |
| Apr 30 2018 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 9.42 | 10,136 | 95,481 | 965,894 | 955.8 K to 965.9 K (+1.06 %) |
| Apr 04 2018 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 1,373 | 0 | 34,532 | 33.2 K to 34.5 K (+4.14 %) |
| Apr 04 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 2,221 | 0 | 63,799 | 61.6 K to 63.8 K (+3.61 %) |
| Apr 04 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 2,221 | 0 | 46,007 | 43.8 K to 46 K (+5.07 %) |
| Apr 04 2018 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 3,258 | 0 | 126,123 | 122.9 K to 126.1 K (+2.65 %) |
| Mar 28 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Sell | S | 7.87 | 15,000 | 118,035 | 272,037 | 287 K to 272 K (-5.23 %) |
| Mar 21 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | M | 0.55 | 50,000 | 27,400 | 50,000 | |
| Mar 21 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Buy | M | 0.55 | 50,000 | 27,400 | 287,037 | 237 K to 287 K (+21.09 %) |
| Feb 15 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | M | 0.55 | 89,938 | 49,286 | 100,000 | |
| Feb 15 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Sell | M | 0.55 | 89,938 | 49,286 | 237,037 | 327 K to 237 K (-27.51 %) |
| Jan 30 2018 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Payment of Exercise | F | 6.25 | 805 | 5,031 | 43,102 | 43.9 K to 43.1 K (-1.83 %) |
| Jan 30 2018 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Payment of Exercise | F | 6.25 | 805 | 5,031 | 79,639 | 80.4 K to 79.6 K (-1.00 %) |
| Jan 30 2018 | CDNA | CareDx, Inc. | Sninsky John Joseph | Chief Scientific Of ... | Payment of Exercise | F | 6.25 | 805 | 5,031 | 22,309 | 23.1 K to 22.3 K (-3.48 %) |
| Jan 30 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Payment of Exercise | F | 6.25 | 1,450 | 9,063 | 147,099 | 148.5 K to 147.1 K (-0.98 %) |
| Jan 25 2018 | CDNA | CareDx, Inc. | Karlsson Anders | Chief Commercial Of ... | Option Exercise | A | 6.31 | 9,638 | 60,816 | 9,638 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Karlsson Anders | Chief Commercial Of ... | Grant | A | 0.00 | 9,638 | 0 | 9,638 | 0 to 9.6 K |
| Jan 25 2018 | CDNA | CareDx, Inc. | King Sasha | Chief Commercial Of ... | Option Exercise | A | 6.31 | 20,000 | 126,200 | 20,000 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | A | 6.31 | 20,000 | 126,200 | 20,000 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Option Exercise | A | 6.31 | 14,013 | 88,422 | 14,013 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Grant | A | 0.00 | 14,013 | 0 | 14,738 | 725 to 14.7 K (+1,932.83 %) |
| Jan 25 2018 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | A | 6.31 | 8,858 | 55,894 | 8,858 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Grant | A | 0.00 | 8,858 | 0 | 82,135 | 73.3 K to 82.1 K (+12.09 %) |
| Jan 25 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 6.31 | 44,425 | 280,322 | 44,425 | |
| Jan 25 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Grant | A | 0.00 | 44,425 | 0 | 152,275 | 107.9 K to 152.3 K (+41.19 %) |
| Jan 23 2018 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Payment of Exercise | F | 6.29 | 1,691 | 10,636 | 43,907 | 45.6 K to 43.9 K (-3.71 %) |
| Jan 23 2018 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Payment of Exercise | F | 6.29 | 1,691 | 10,636 | 71,586 | 73.3 K to 71.6 K (-2.31 %) |
| Jan 23 2018 | CDNA | CareDx, Inc. | Sninsky John Joseph | Chief Scientific Of ... | Payment of Exercise | F | 6.29 | 886 | 5,573 | 23,114 | 24 K to 23.1 K (-3.69 %) |
| Jan 23 2018 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Payment of Exercise | F | 6.29 | 3,726 | 23,437 | 104,124 | 107.9 K to 104.1 K (-3.45 %) |
| Jan 02 2018 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 2,004 | 0 | 43,786 | 41.8 K to 43.8 K (+4.80 %) |
| Jan 02 2018 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 1,844 | 0 | 33,159 | 31.3 K to 33.2 K (+5.89 %) |
| Jan 02 2018 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 3,074 | 0 | 122,865 | 119.8 K to 122.9 K (+2.57 %) |
| Jan 02 2018 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 1,924 | 0 | 61,578 | 59.7 K to 61.6 K (+3.23 %) |
| Dec 08 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | M | 3.36 | 29,197 | 98,000 | 0 | |
| Dec 08 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Sell | S | 7.00 | 29,197 | 204,379 | 45,598 | 74.8 K to 45.6 K (-39.04 %) |
| Dec 08 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Buy | M | 3.36 | 29,197 | 98,000 | 74,795 | 45.6 K to 74.8 K (+64.03 %) |
| Nov 30 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | M | 3.36 | 10,948 | 36,785 | 0 | |
| Nov 30 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Sell | S | 7.17 | 10,948 | 78,487 | 73,277 | 84.2 K to 73.3 K (-13.00 %) |
| Nov 30 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Buy | M | 3.36 | 10,948 | 36,785 | 84,225 | 73.3 K to 84.2 K (+14.94 %) |
| Nov 13 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | A | 5.49 | 13,359 | 73,341 | 13,359 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | D | 12.40 | 21,897 | 271,523 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Option Exercise | A | 5.49 | 37,453 | 205,617 | 37,453 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Option Exercise | D | 12.40 | 61,386 | 761,186 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 5.49 | 69,474 | 381,412 | 69,474 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | D | 12.40 | 113,868 | 1,411,963 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | A | 5.49 | 8,906 | 48,894 | 8,906 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | D | 12.40 | 14,597 | 181,003 | 0 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 5.49 | 6,679 | 36,668 | 6,679 | |
| Nov 13 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | D | 12.40 | 10,948 | 135,755 | 0 | |
| Oct 30 2017 | CDNA | CareDx, Inc. | King Sasha | Chief Commercial Of ... | Option Exercise | A | 5.90 | 40,000 | 236,000 | 40,000 | |
| Oct 30 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 5.90 | 45,000 | 265,500 | 45,000 | |
| Oct 30 2017 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Option Exercise | A | 5.90 | 45,000 | 265,500 | 45,000 | |
| Oct 06 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 4.00 | 1,278 | 5,112 | 40,529 | 39.3 K to 40.5 K (+3.26 %) |
| Oct 06 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 4.00 | 9,364 | 37,456 | 928,768 | 919.4 K to 928.8 K (+1.02 %) |
| Oct 04 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,951 | 0 | 41,782 | 35.8 K to 41.8 K (+16.61 %) |
| Oct 04 2017 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 9,125 | 0 | 119,791 | 110.7 K to 119.8 K (+8.25 %) |
| Oct 04 2017 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 5,475 | 0 | 31,315 | 25.8 K to 31.3 K (+21.19 %) |
| Oct 04 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,713 | 0 | 59,654 | 53.9 K to 59.7 K (+10.59 %) |
| Sep 08 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 3.05 | 856 | 2,611 | 39,251 | 38.4 K to 39.3 K (+2.23 %) |
| Sep 08 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 3.05 | 2,858 | 8,717 | 919,404 | 916.5 K to 919.4 K (+0.31 %) |
| Sep 08 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 3.05 | 2,782 | 8,485 | 916,546 | 913.8 K to 916.5 K (+0.30 %) |
| Sep 05 2017 | CDNA | CareDx, Inc. | Sninsky John Joseph | Chief Scientific Of ... | Option Exercise | A | 2.80 | 10,000 | 28,000 | 10,000 | |
| Sep 05 2017 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Option Exercise | A | 2.80 | 10,000 | 28,000 | 10,000 | |
| Sep 05 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | A | 2.80 | 10,000 | 28,000 | 10,000 | |
| Sep 05 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | A | 2.80 | 10,000 | 28,000 | 10,000 | |
| Sep 05 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 2.80 | 25,000 | 70,000 | 25,000 | |
| Aug 30 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.77 | 2,410 | 6,676 | 38,395 | 36 K to 38.4 K (+6.70 %) |
| Aug 30 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.77 | 10,033 | 27,791 | 913,764 | 903.7 K to 913.8 K (+1.11 %) |
| Aug 30 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.77 | 9,005 | 24,944 | 903,731 | 894.7 K to 903.7 K (+1.01 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.93 | 4,960 | 14,533 | 118,389 | 113.4 K to 118.4 K (+4.37 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 3.19 | 19,577 | 62,451 | 113,429 | 93.9 K to 113.4 K (+20.86 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.93 | 760 | 2,227 | 35,985 | 35.2 K to 36 K (+2.16 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.39 | 1,312 | 3,136 | 35,225 | 33.9 K to 35.2 K (+3.87 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.39 | 4,253 | 10,165 | 894,726 | 890.5 K to 894.7 K (+0.48 %) |
| Aug 28 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.39 | 4,257 | 10,174 | 890,473 | 886.2 K to 890.5 K (+0.48 %) |
| Aug 16 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Buy | P | 1.82 | 350 | 637 | 107,850 | 107.5 K to 107.9 K (+0.33 %) |
| Aug 16 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Buy | P | 1.82 | 150 | 273 | 107,500 | 107.4 K to 107.5 K (+0.14 %) |
| Aug 16 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Buy | P | 1.81 | 100 | 181 | 107,350 | 107.3 K to 107.4 K (+0.09 %) |
| Aug 16 2017 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Buy | P | 1.84 | 350 | 645 | 725 | 375 to 725 (+93.33 %) |
| Aug 16 2017 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Buy | P | 1.81 | 375 | 680 | 375 | 0 to 375 |
| Jul 25 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.23 | 1,486 | 1,828 | 955,758 | 954.3 K to 955.8 K (+0.16 %) |
| Jul 14 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | Bickerstaff George | Director | Grant | A | 0.00 | 5,000 | 0 | 35,831 | 30.8 K to 35.8 K (+16.22 %) |
| Jul 14 2017 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | Goldberg Michael | Director | Grant | A | 0.00 | 5,000 | 0 | 110,666 | 105.7 K to 110.7 K (+4.73 %) |
| Jul 14 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 5,000 | 0 | 32,901 | 27.9 K to 32.9 K (+17.92 %) |
| Jul 14 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | SNYDERMAN RALPH | Director | Grant | A | 0.00 | 5,000 | 0 | 53,941 | 48.9 K to 53.9 K (+10.22 %) |
| Jul 14 2017 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Option Exercise | A | 1.22 | 15,000 | 18,300 | 15,000 | |
| Jul 14 2017 | CDNA | CareDx, Inc. | HAGSTROM WILLIAM A | Director | Grant | A | 0.00 | 5,000 | 0 | 25,840 | 20.8 K to 25.8 K (+23.99 %) |
| Jul 03 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.11 | 1,808 | 2,007 | 954,272 | 952.5 K to 954.3 K (+0.19 %) |
| Jun 27 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.10 | 63,120 | 69,432 | 203,484 | 140.4 K to 203.5 K (+44.97 %) |
| May 26 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.00 | 6,302 | 6,302 | 886,216 | 879.9 K to 886.2 K (+0.72 %) |
| May 26 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.00 | 1,137 | 1,137 | 879,914 | 878.8 K to 879.9 K (+0.13 %) |
| May 24 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.04 | 1,987 | 2,066 | 33,913 | 31.9 K to 33.9 K (+6.22 %) |
| May 24 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.04 | 4,849 | 5,043 | 878,777 | 873.9 K to 878.8 K (+0.55 %) |
| May 02 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 0.89 | 15,116 | 13,453 | 873,928 | 858.8 K to 873.9 K (+1.76 %) |
| Apr 25 2017 | CDNA | CareDx, Inc. | Bell Michael Brian | Chief Financial Off ... | Option Exercise | A | 1.00 | 40,000 | 40,000 | 40,000 | |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.66 | 27 | 45 | 31,926 | 31.9 K to 31.9 K (+0.08 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.66 | 24,852 | 41,254 | 140,364 | 115.5 K to 140.4 K (+21.51 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.66 | 40,899 | 67,892 | 858,812 | 817.9 K to 858.8 K (+5.00 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 1.66 | 35,406 | 58,774 | 817,913 | 782.5 K to 817.9 K (+4.52 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.60 | 2,930 | 7,618 | 31,899 | 29 K to 31.9 K (+10.11 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.60 | 4,374 | 11,372 | 782,507 | 778.1 K to 782.5 K (+0.56 %) |
| Mar 20 2017 | CDNA | CareDx, Inc. | GAGNON NEIL | 10% Owner | Buy | P | 2.60 | 14,672 | 38,147 | 778,133 | 763.5 K to 778.1 K (+1.92 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Karlsson Anders | See Remarks | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Karlsson Anders | See Remarks | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Option Exercise | A | 2.30 | 60,000 | 138,000 | 60,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Maag Peter | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 107,250 | 89.3 K to 107.3 K (+20.17 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Sninsky John Joseph | Chief Scientific Of ... | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Sninsky John Joseph | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 24,000 | 14 K to 24 K (+71.43 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Whitson Todd | Chief Commercial Of ... | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Whitson Todd | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Nelles Mitchell J | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 73,277 | 63.3 K to 73.3 K (+15.80 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Yee James P | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 45,598 | 35.6 K to 45.6 K (+28.09 %) |
| Feb 22 2017 | CDNA | CareDx, Inc. | Constanti Charles | Chief Financial Off ... | Option Exercise | A | 2.30 | 27,000 | 62,100 | 27,000 | |
| Feb 22 2017 | CDNA | CareDx, Inc. | Constanti Charles | Chief Financial Off ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 04 2017 | CDNA | CareDx, Inc. | Cohen Fred E | Director | Grant | A | 0.00 | 3,391 | 0 | 22,630 | 19.2 K to 22.6 K (+17.63 %) |